Science. 2010 May 7;328(5979):745-8.

Cross-reacting antibodies enhance dengue virus infection in humans.

Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G.

Source

Department of Medicine, Imperial College London, London W12 0NN, UK.

Erratum in

Science. 2010 Jul 9;329(5988):142.

Abstract

Dengue virus co-circulates as four serotypes, and sequential infections with more than one serotype are common. One hypothesis for the increased severity seen in secondary infections is antibody-dependent enhancement (ADE) leading to increased replication in Fc receptor-bearing cells. In this study, we have generated a panel of human monoclonal antibodies to dengue virus. Antibodies to the structural precursor-membrane protein (prM) form a major component of the response. These antibodies are highly cross-reactive among the dengue virus serotypes and, even at high concentrations, do not neutralize infection but potently promote ADE. We propose that the partial cleavage of prM from the viral surface reduces the density of antigen available for viral neutralization, leaving dengue viruses susceptible to ADE by antibody to prM, a finding that has implications for future vaccine design.

PMID:: 20448183; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Dengue - MedlinePlus Health Information

Supplemental Content

Related citations

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. [Cell Host Microbe. 2010]
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.
Beltramello M, Williams KL, Simmons CP, Macagno A, Simonelli L, Quyen NT, Sukupolvi-Petty S, Navarro-Sanchez E, Young PR, de Silva AM, et al. Cell Host Microbe. 2010 Sep 16; 8(3):271-83.
An in-depth analysis of original antigenic sin in dengue virus infection. [J Virol. 2011]
An in-depth analysis of original antigenic sin in dengue virus infection.
Midgley CM, Bajwa-Joseph M, Vasanawathana S, Limpitikul W, Wills B, Flanagan A, Waiyaiya E, Tran HB, Cowper AE, Chotiyarnwong P, et al. J Virol. 2011 Jan; 85(1):410-21. Epub 2010 Oct 27.
Response to dengue fever--the good, the bad, and the ugly? [N Engl J Med. 2010]
Response to dengue fever--the good, the bad, and the ugly?
Schmidt AC. N Engl J Med. 2010 Jul 29; 363(5):484-7.
Review Immune response to dengue virus and prospects for a vaccine. [Annu Rev Immunol. 2011]
Review Immune response to dengue virus and prospects for a vaccine.
Murphy BR, Whitehead SS. Annu Rev Immunol. 2011 Apr 23; 29:587-619.
Review Domain III of the envelope protein as a dengue vaccine target. [Expert Rev Vaccines. 2010]
Review Domain III of the envelope protein as a dengue vaccine target.
Guzman MG, Hermida L, Bernardo L, Ramirez R, Guillén G. Expert Rev Vaccines. 2010 Feb; 9(2):137-47.

See reviews... See all...

Cited by 25 PubMed Central articles

Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay. [PLoS Negl Trop Dis. 2012]
Analysis of epitopes on dengue virus envelope protein recognized by monoclonal antibodies and polyclonal human sera by a high throughput assay.
Lin HE, Tsai WY, Liu IJ, Li PC, Liao MY, Tsai JJ, Wu YC, Lai CY, Lu CH, Huang JH, et al. PLoS Negl Trop Dis. 2012 Jan; 6(1):e1447. Epub 2012 Jan 3.
Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection. [PLoS One. 2011]
Dengue virus activates polyreactive, natural IgG B cells after primary and secondary infection.
Balakrishnan T, Bela-Ong DB, Toh YX, Flamand M, Devi S, Koh MB, Hibberd ML, Ooi EE, Low JG, Leo YS, et al. PLoS One. 2011; 6(12):e29430. Epub 2011 Dec 22.
IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. [PLoS Negl Trop Dis. 2011]
IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
Fagundes CT, Costa VV, Cisalpino D, Amaral FA, Souza PR, Souza RS, Ryffel B, Vieira LQ, Silva TA, Atrasheuskaya A, et al. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1449. Epub 2011 Dec 20.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cross-reacting antibodies enhance dengue virus infection in humans.
Cross-reacting antibodies enhance dengue virus infection in humans.
Science. 2010 May 7 ;328(5979):745-8.

PubMed
TRPing the switch on pain: an introduction to the chemistry and biology of capsa...
TRPing the switch on pain: an introduction to the chemistry and biology of capsaicin and TRPV1.
Chem Soc Rev. 2008 Aug ;37(8):1530-45. Epub 2008 Jun 20 .

PubMed
Streptokinase-induced platelet activation involves antistreptokinase antibodies ...
Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1.
Blood. 2000 Feb 15 ;95(4):1301-8.

PubMed
Fibroblast growth factor-binding protein is a novel partner for perlecan protein...
Fibroblast growth factor-binding protein is a novel partner for perlecan protein core.
J Biol Chem. 2001 Mar 30 ;276(13):10263-71. Epub 2001 Jan 8 .

PubMed
Oxidative stress and neurotoxicity.
Oxidative stress and neurotoxicity.
Chem Res Toxicol. 2008 Jan ;21(1):172-88. Epub 2007 Dec 4 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: